Shruti Singh, MD
Medical Oncology / Hematology
Location
Dyer
1001 Calumet Avenue, Dyer, IN 46311
Phone: 219-924-8178
Fax: 219-924-8179
Provider Availability: Mon, Tues, Thurs, Fri
Medical School
University of Tennessee College of Medicine
Residency
Loyola University Medical Center
Fellowship
Loyola University Medical Center
Board Certification
American Board of Internal Medicine - Internal Medicine 2016American Board of Internal Medicine - Hematology 2019
American Board of Internal Medicine - Medical Oncology 2019
Affiliations
American Society of Clinical Oncology
American College of Physicians
American Medical Association
American Society of Hematology
American Association of Physicians of Indian Origin
Languages
English, Hindi
Biography
Dr. Shruti Singh is a board-certified medical oncologist and hematologist practicing in the community setting, with a commitment to bringing comprehensive, innovative cancer care and clinical research closer to patients.
Her clinical practice encompasses both benign and malignant hematology and a broad range of solid tumors, with particular interests in women’s cancers and thoracic (lung), gastrointestinal (digestive system), and genitourinary (urinary system) malignancies. A central focus of her work has been expanding access to advanced cancer therapies traditionally concentrated at large academic medical centers. Dr. Singh played a leading role in bringing cellular and immune effector therapies to Northwest Indiana, including the development of an outpatient bispecific antibody therapy program that allows eligible patients to receive these innovative treatments closer to home.
Beyond active cancer treatment, Dr. Singh has a strong interest in survivorship and cancer prevention. She emphasizes evidence-based lifestyle interventions, particularly exercise and nutrition, as important components of long-term health and wellness for cancer survivors.
Dr. Singh’s prior research has examined outcomes associated with sequential immunotherapy, hematopoietic stem cell transplantation in older adults, and the treatment of older patients with aggressive non-Hodgkin lymphoma. She currently serves as Research Director at Northwest Cancer Centers, where she has helped expand the organization’s clinical research program and access to Phase I–IV clinical trials for patients throughout Northwest Indiana. Her work reflects a broader commitment to ensuring that patients treated in the community have access to cutting-edge therapies and clinical research opportunities without necessarily having to travel to a major academic center.
Dr. Singh joined Northwest Cancer Centers at its Dyer location in 2019. Since entering clinical practice, she has remained focused on combining compassionate, individualized care with innovation, research, and expanded access to advanced cancer therapies for patients in Northwest Indiana.